282 related articles for article (PubMed ID: 26972146)
1. Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers.
Williams J; Holmes RP; Assimos DG; Mitchell T
Urology; 2016 Jul; 93():224.e1-6. PubMed ID: 26972146
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
[No Abstract] [Full Text] [Related]
4. Metabolic syndrome and the risk of calcium stones.
Sakhaee K; Capolongo G; Maalouf NM; Pasch A; Moe OW; Poindexter J; Adams-Huet B
Nephrol Dial Transplant; 2012 Aug; 27(8):3201-9. PubMed ID: 22247230
[TBL] [Abstract][Full Text] [Related]
5. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
[TBL] [Abstract][Full Text] [Related]
6. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
[TBL] [Abstract][Full Text] [Related]
7. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.
Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942
[TBL] [Abstract][Full Text] [Related]
9. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
10. Risk of Chronic Kidney Disease in Brushite Stone Formers Compared With Idiopathic Calcium Oxalate Stone Formers.
Rivera M; Jaeger C; Yelfimov D; Krambeck AE
Urology; 2017 Jan; 99():23-26. PubMed ID: 27634734
[TBL] [Abstract][Full Text] [Related]
11. Oxalate disrupts monocyte and macrophage cellular function via Interleukin-10 and mitochondrial reactive oxygen species (ROS) signaling.
Kumar P; Laurence E; Crossman DK; Assimos DG; Murphy MP; Mitchell T
Redox Biol; 2023 Nov; 67():102919. PubMed ID: 37806112
[TBL] [Abstract][Full Text] [Related]
12. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
Khan SR; Glenton PA; Backov R; Talham DR
Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
[TBL] [Abstract][Full Text] [Related]
13. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
14. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers.
Tsujihata M; Miyake O; Yoshimura K; Kakimoto K; Takahara S; Okuyama A
Eur Urol; 2001 Oct; 40(4):458-62. PubMed ID: 11713403
[TBL] [Abstract][Full Text] [Related]
15. Examination of the urinary potential of hyperuricosuric patients to retard calcium oxalate precipitation.
Goldwasser B; Sarig S; Azoury R; Orda S; Boichis H; Wax Y; Many M
Eur Urol; 1985; 11(1):40-3. PubMed ID: 3987747
[TBL] [Abstract][Full Text] [Related]
16. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
17. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
18. 24-Hour Urine Calcium Oxalate Supersaturation Risk Correlates with Computerized Tomography Volumetric Calcium Oxalate Stone Growth.
Yuzhakov S; Steadman SD; Otto BJ; Bird VG; Canales BK
J Urol; 2021 Dec; 206(6):1438-1444. PubMed ID: 34288713
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.
Viers BR; Lieske JC; Vrtiska TJ; Herrera Hernandez LP; Vaughan LE; Mehta RA; Bergstralh EJ; Rule AD; Holmes DR; Krambeck AE
Urology; 2015 Apr; 85(4):771-6. PubMed ID: 25681832
[TBL] [Abstract][Full Text] [Related]
20. The role of Tamm-Horsfall mucoprotein in calcium oxalate crystallization. N-acetylcysteine--a new therapy for calcium oxalate urolithiasis.
Fan J; Shen SJ
Br J Urol; 1994 Sep; 74(3):288-93. PubMed ID: 7953256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
